Efficacy and Safety of BBT-401-1S in Ulcerative Colitis
Clinical trial NCT03800420 · TERMINATED
Trial details
- NCT number
- NCT03800420
- Sponsor
- Bridge Biotherapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-22
- Primary completion
- 2020-05-18
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.